For weight loss, walking at a moderate pace for 30-45 minutes per day, or 150 minutes per week, is generally recommended and ...

A special investigation by the Manchester Evening New's Nicole Wootton-Cane has revealed the Ozempic and Wegovy sold on the ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

Novo Nordisk's amycretin trial results highlight significant weight loss in adults with obesity, with further clinical ...